De Rucci Healthy Sleep Co., Ltd. (SHE:001323)
China flag China · Delayed Price · Currency is CNY
16.89
-0.68 (-3.87%)
Oct 30, 2026, 3:04 PM CST

De Rucci Healthy Sleep Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
312.06535.53767.33802.27708.41686.44
Depreciation & Amortization
241.92249.18236.46230.59253.27204.87
Other Amortization
45.538.2424.6123.1457.4128.12
Loss (Gain) From Sale of Assets
-2.57-2.578-7.17-29.314.52
Asset Writedown & Restructuring Costs
0.140.141.47.411.110.39
Loss (Gain) From Sale of Investments
-133.02-133.02-36.52-2.06-1.72-4.26
Provision & Write-off of Bad Debts
-----2.81
Other Operating Activities
391.585.4818.56.6916.313.66
Change in Accounts Receivable
-96.65-96.65-0.06231.44-173.29-81.07
Change in Inventory
-50.46-50.4629.96-24.7476.44-35.79
Change in Accounts Payable
-132.32-132.325.89646.67-267.45197.06
Change in Other Net Operating Assets
-22.44-22.4426.7---
Operating Cash Flow
547.72385.11,0911,935647.44994.61
Operating Cash Flow Growth
-34.68%-64.69%-43.63%198.82%-34.91%0.83%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-224.55-223.09-380.68-395.67-621.74-768.18
Sale of Property, Plant & Equipment
5.481.374.720.715.041.01
Cash Acquisitions
-83.95-194.41----
Investment in Securities
77.1327.08-1,789-557.8-700-
Other Investing Activities
92.03133.6627.451.350.994.26
Investing Cash Flow
-133.8944.61-2,137-951.41-1,316-762.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,9332,207634.91--
Long-Term Debt Repaid
--1,908-1,612-229.55-74.68-76.34
Lease Payments
-32.83-32.83-21.16-36.55-74.68-76.34
Net Debt Issued (Repaid)
175.1724.76595.01405.36-74.68-76.34
Issuance of Common Stock
----1,484-
Repurchase of Common Stock
-24.79-14.79-227.42-123.56--
Common Dividends Paid
-466.27-598.44-699.08-404.73-400.01-
Other Financing Activities
28.65440.6910.11-468.29-15.43-5.43
Financing Cash Flow
-287.24-147.79-321.38-591.21993.83-81.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.85-0.030.240.432.31-0.3
Net Cash Flow
125.74281.89-1,368392.5327.87149.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
323.17162.01709.841,53925.7226.43
Free Cash Flow Growth
-47.73%-77.18%-53.88%5887.53%-88.65%-57.29%
Free Cash Flow Margin
6.24%3.10%12.67%27.59%0.44%3.49%
Free Cash Flow Per Share
0.740.381.643.500.060.57
Levered Free Cash Flow
62.844.8637.521,015-323.45-57.29
Unlevered Free Cash Flow
64.2357.09648.691,021-317.65-50.52
Free Cash Flow After Leases
290.34129.19688.681,502-48.98150.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
343.38484.67495.67448.85461.97498.88
Change in Working Capital
-307.88-307.8870.74873.83-358.0458.07